Report 2013 – 2014

Report 2013 – 2014

Pfizer PAC Our Voices. Our Impact. Pfizer PAC and Corporate Political Contributions Report January 2013 – December 2014 Pfizer PAC – Our Voices. Our Impact. A Message from Sally Susman, Chair, Pfizer PAC I am pleased to share our annual 2014 election cycle political contributions report, which includes a list of candidates and political committees supported either by Pfizer or the Pfizer PAC from January 1, 2013 through December 31, 2014. The Pfizer PAC is bipartisan; we contribute to candidates of both political parties. This cycle we supported 2,032 candidates at all levels of government with 55% of the PAC contributions given to Republicans and 45% to Democrats. I hope you will take time to review the report to see which candidates the PAC supported in your state and community. We continue to face significant legislative and regulatory challenges and each election cycle is critical to our industry. Our elected representatives are making difficult choices, including focusing on cost reductions that could fundamentally affect our ability to compete and innovate. Pfizer’s goal is to bring innovative therapies to patients that significantly improve their lives. We do that by generating sustained, positive “public will” among the general public, policymakers, and all of our stakeholders to help build constructive discourse in the political and regulatory environment in support of short-and long-term business priorities, including the protection of intellectual property; fair and comprehensive tax reform, protecting Medicare Part D from the impact of the debt and deficit reduction negotiations and demonstrating our value to patients by showing key opinion leaders, elected officials and the public at large how we improve and save lives. As Pfizer’s PAC Chair and through my interactions with elected officials, I see first-hand how decisions are made that impact our ability to discover and bring to market innovative medicines and vaccines. The Pfizer PAC supports candidates who are committed to maintaining and improving incentives for innovation and protecting and expanding access for the patients we serve. Thank you for your support, Sally Susman Chair, Pfizer PAC 2 PFIZER PAC Our Voices, Our Impact. What is a PAC? Who Receives Pfizer PAC Contributions? PAC stands for Political Action Committee. A political action com- Pfizer PAC is nonpartisan. It sup- mittee is a government-regulated ports Democrats and Republicans organization that anyone can form alike. From January 2013 through to raise money for political cam- December 2014 Pfizer PAC sup- paign donations. PACs are formed ported 2,032 candidates. True by individuals, non-profits, and to its nonpartisan values, Pfizer even many major corporations. PAC is committed to support candidates from both political How Does Pfizer PAC Work? parties who share Pfizer’s vision and values for healthcare. When The Pfizer political action commit- choosing to make a contribution tee, Pfizer PAC, is a nonpartisan -or to a candidate, the Pfizer PAC ganization that provides opportu- considers candidates’ views on nities for employees to participate issues that impact Pfizer and its in the American political process. employees as well as the presence The Pfizer PAC is an employee-run of Pfizer facilities or employees in organization with a Steering Com- the candidate’s district or state. mittee made up of Pfizer employ- A complete list of Pfizer PAC and ees from different divisions of the state corporate political contribu- company. All corporate PACs are tions for January 2013 - December funded by voluntary employee 2014 is included in this report. contributions. Pfizer PAC is no different; it relies on the participa- tion of Pfizer colleagues. 3 Pfizer PAC & Political Contributions Governance Policy Pfizer complies fully with all federal, state, and local laws and reporting requirements governing PAC and corporate political contributions. Pfizer has a Corporate Policy Procedure (#802a) that requires all PAC and corporate political contributions to be compiled and published semiannually in a report that is made available to employees, shareholders, and the public, and posted on the Company’s website at www.pfizer.com in “Lobbying and Political Contributions” under the “About Pfizer” tab within the “Corporate Governance” section. At the end of each Federal cycle (every two years), the Pfizer PAC is audited by Bond Beebe, a certified public accounting and advisory firm. Pfizer also requests that trade associations receiving total payments of $100,000 or more from Pfizer in a given year report the portion of Pfizer dues or payments used for expenditures or contributions that, if made directly by Pfizer, would not be deductible under section 162(e)(1)(B) of the Internal Revenue Code. We are disclosing such information received from our trade associations in this report. Pfizer has a PAC Steering Committee comprised of eight colleagues who review and approve all PAC and corporate political contributions on a monthly basis. To ensure adequate representation, Steering Committee members represent different divisions within the Pfizer organization. The PAC Steering Committee evaluates candidates on a basis of their views on issues that impact Pfizer and its colleagues. It also takes note of whether Pfizer facilities or colleagues reside in a candidate’s district or state. In addition, all PAC and corporate contribution requests are shared with the Pfizer Political Contributions Policy Committee for review. The Political Contributions Policy Committee is responsible for governing the Pfizer PAC. Pfizer does not traditionally make contributions to 527 Issue Organizations. If we were asked to make such a contribution, it would have to be reviewed and approved by the Political Contributions Policy Committee and subsequently disclosed in our semi-annual report. Finally, in light of the Supreme Court decision in the Citizens United case, Pfizer has determined that it will not make any direct independent expenditures, a decision which has been discussed at the executive level as well as with the Corporate Governance Committee of our Board. 4 Political Contributions Policy Committee CHAIR Atiba Adams Rod MacKenzie Sally Susman Corporate Secretary & Senior Vice President & Executive Vice President, Chief Governance Counsel, Head of Pharma Therapeutics, Corporate Affairs Corporate Governance Research & Development TREASURER Ken Cole Tony Maddaluna Joseph Gruber Senior Vice President, Executive Vice President & Senior Vice President, US Government Relations President, Global Tax Pfizer Global Supply SECRETARY Geno Germano Marc Scarduffa Barbara Bonfiglio Group President, Vice President, Senior Corporate Counsel, Global Innovative Pharma US Government Relations & Corporate Governance US Public Affairs Robert Jones Julie Schiffman Vice President, Vice President, National Government Relations Portfolio & Decision Analysis Jeff Keisling Senior Vice President & Chief Information Officer, Business Technology Doug Lankler Executive Vice President, Chief General Counsel Pfizer PAC Steering Committee Susan Anderson Michael Flesher John F. Kelly Senior Director, Director, Vice President, Research & Development Pfizer Medical Strategy & Transitioning Sites Groton, CT Chicago, IL New York, NY Sheryl Colyer Mike Hoffman Dennis Ryan Vice President, Vice President, Regional Manager, Human Resources Global Procurement Global Established Pharma New York, NY Peapack, NJ La Jolla, CA Richard Dudek Bill Kennally Senior Regional Business Director, Business Lead, Global Oncology Global Established Pharma Itasca, IL Peapack, NJ 5 Pfizer PAC Our Voices. Our Impact. Political Contributions Recipients January 2013 – December 2014 Pfizer Political Contributions RecipientsJanuary 2013 - December 2014 State/Office Win Fullname Party Dist. Corp. PAC ALABAMA US HOUSE W Rep. Robert B. Aderholt R 004 $7,000.00 W Rep. Bradley Byrne R 001 $5,000.00 Paul DeMarco R 006 $1,000.00 W Rep. Terri A. Sewell D 007 $1,000.00 GOVERNOR W Gov. Robert J. Bentley R $5,000.00 STATE ATTORNEY GENERAL W AG Luther Johnson Strange, III R $10,000.00 STATE SENATE W Sen. Arthur Orr R 003 $1,000.00 W Sen. Gregory Reed R 005 $1,000.00 W Sen. Cam Ward R 014 $1,000.00 W Sen. Tim Melson R 001 $500.00 W Sen. Del Marsh R 012 $2,000.00 W Sen. Slade Blackwell R 015 $500.00 STATE HOUSE W Rep. Jack Williams R 047 $1,000.00 W Rep. James Patterson R 021 $500.00 W Rep. Becky Nordgren R 029 $500.00 W Rep. April Weaver R 049 $1,000.00 W Rep. Steve Clouse R 093 $1,000.00 ALASKA US SENATE Mark Peter Begich D $7,500.00 ARIZONA US HOUSE Ron Barber D 002 $2,000.00 W Rep. Ann Kirkpatrick D 001 $1,000.00 W Rep. Matt Salmon R 005 $5,500.00 W Rep. Kyrsten Sinema D 009 $4,000.00 W NP Winner Non-Partisan Debt-Retirement Facility 7 Pfizer Political Contributions RecipientsJanuary 2013 - December 2014 State/Office Win Fullname Party Dist. Corp. PAC GOVERNOR Fred DuVal D $3,500.00 W Gov. Doug Ducey R $2,000.00 STATE ATTORNEY GENERAL W AG Mark Brnovich R $2,000.00 STATE SENATE W Sen. Nancy K. Barto R 015 $600.00 W Sen. Andy Biggs R 012 $600.00 W Sen. David T. Bradley D 010 $400.00 W Sen. Judy M. Burges R 022 $600.00 Olivia Cajero Bedford D 003 $200.00 Chester Crandell R 006 $200.00 W Sen. Jeff Dial R 018 $900.00 W Sen. Adam Driggs R 028 $600.00 W Sen. Steve Farley D 009 $200.00 Steve M. Gallardo D 029 $200.00 W Sen. Gail Griffin R 014 $400.00 W Sen. Katie Hobbs D 024 $400.00 W Sen. John Kavanagh R 023 $200.00 W Sen. Debbie Lesko R 021 $200.00 John McComish R 018 $200.00 W Sen. Lynne Pancrazi D 004 $200.00 W Sen. Steve Pierce R 001 $500.00 W Sen. Martin J. Quezada D 029 $400.00 W Sen. Don Shooter R 013 $200.00 Anna Tovar D 019 $200.00 W Sen. Kelli Ward R 005 $800.00 W Sen.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    102 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us